American Century Non-US IntrsVal Inv holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
American Century Non-U.S. IntrinsicValue Fund Investor Class ANTUX
- NAV / 1-Day Return 10.61 / −2.21 %
- Total Assets 530.9M
-
Adj. Expense Ratio
1.180%
- Expense Ratio 1.180%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 3.53%
- Turnover 71%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:09 AM GMT+0
Morningstar’s Analysis ANTUX
Will ANTUX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ANTUX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ANTUX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Shell PLC | 4.46 | 23M | Energy |
GSK PLC | 4.37 | 22M | Healthcare |
Repsol SA | 3.47 | 18M | Energy |
Alstom SA | 3.37 | 17M | Industrials |
Eni SpA | 3.15 | 16M | Energy |
Banco Santander SA | 2.89 | 15M | Financial Services |
BNP Paribas Act. Cat.A | 2.84 | 15M | Financial Services |
PT Telkom Indonesia (Persero) Tbk Registered Shs Series -B- | 2.71 | 14M | Communication Services |
AstraZeneca PLC | 2.69 | 14M | Healthcare |
Heineken NV | 2.69 | 14M | Consumer Defensive |
United States